A review of augmentation therapy for alpha-1 antitrypsin deficiency.
about
Rationale and design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis. Alpha-1 protocolMechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetesMechanisms of protein-folding diseases at a glanceDetermination of alpha-1 antitrypsin level in patients with severe asthma.Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.The Saudi Guidelines for the Diagnosis and Management of COPD.The challenge of detecting alpha-1 antitrypsin deficiency.Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functionsClinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.Safety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK).High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema.Detecting Alpha-1 Antitrypsin Deficiency.Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
P2860
Q23911017-3E7BA5F7-20BF-480F-A17E-BAE7BEFC3FFAQ26861561-9FD4BA6F-AB43-4CC3-A642-0C7EA6993C5FQ27003095-108CA451-4489-4210-8412-24757A1B04B3Q34126916-48549AE6-2111-4170-B7AC-F3ADA9CC2A81Q35031693-3B89DB4A-BE1D-4254-9C99-1730E91BBCB4Q37733309-8CDEBD92-B002-4A74-8049-A64E1B53AE59Q38092856-24AF51EF-5684-4616-BBCE-0DE3F059194FQ38711081-843B63D3-B26A-4E40-BE43-2C5F2CEB87C1Q41138327-8A71DA13-A977-44D9-B5E1-107FC9B99972Q46774150-85317894-D6AF-4713-8C4D-5F40C6C19BC6Q47747847-AD88E3D7-227F-45D4-AF82-15136BCE18E4Q48093044-B35D55B7-7E07-49D4-B294-91F8330EF023Q53075740-AC6524EE-B9E7-4742-96C1-233DF574C829
P2860
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@ast
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@en
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@nl
type
label
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@ast
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@en
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@nl
prefLabel
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@ast
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@en
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@nl
P2093
P2860
P1476
A review of augmentation therapy for alpha-1 antitrypsin deficiency.
@en
P2093
Danai Khemasuwan
James K Stoller
Manish Mohanka
P2860
P304
P356
10.1517/14712598.2012.676638
P407
P577
2012-04-14T00:00:00Z